Detalles de la búsqueda
1.
PGE1 and PGE2 modify platelet function through different prostanoid receptors.
Prostaglandins Other Lipid Mediat
; 94(1-2): 9-16, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21095237
2.
PD-1 blockade augments anti-neuroblastoma immune response induced by anti-GD2 antibody ch14.18/CHO.
Oncoimmunology
; 6(10): e1343775, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29123953
3.
Generation and Characterization of a Human/Mouse Chimeric GD2-Mimicking Anti-Idiotype Antibody Ganglidiximab for Active Immunotherapy against Neuroblastoma.
PLoS One
; 11(3): e0150479, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26967324
4.
Neuroblastoma patients with high-affinity FCGR2A, -3A and stimulatory KIR 2DS2 treated by long-term infusion of anti-GD2 antibody ch14.18/CHO show higher ADCC levels and improved event-free survival.
Oncoimmunology
; 5(11): e1235108, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27999754
5.
Pharmacokinetics and pharmacodynamics of ch14.18/CHO in relapsed/refractory high-risk neuroblastoma patients treated by long-term infusion in combination with IL-2.
MAbs
; 8(3): 604-16, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26785755
6.
Functional bioassays for immune monitoring of high-risk neuroblastoma patients treated with ch14.18/CHO anti-GD2 antibody.
PLoS One
; 9(9): e107692, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25226154
7.
Validated detection of human anti-chimeric immune responses in serum of neuroblastoma patients treated with ch14.18/CHO.
J Immunol Methods
; 407: 108-15, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24727144
Resultados
1 -
7
de 7
1
Próxima >
>>